Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Curr Osteoporos Rep. 2020 Jun;18(3):210–227. doi: 10.1007/s11914-020-00570-x

Figure 4.

Figure 4.

Inhibition of IGF-1R Signaling. The IGF-1 peptide analog, JB1, competitively binds to the IGF-1R. JB1 thus inhibits IGF-1 binding and prevents IGF-1R activation, ultimately blocking kinase signaling that would otherwise lead to cell survival and proliferation (repressed downstream effects indicated by the red “X”). Illustration based on Crudden, Girnita, A, and Girnita, L. [159].